Sign in
CompletedNo phase

Hormone Evaluation in Artificial Reproductive Technology

Key facts

Who runs it
Lund University
Where
Poland and Sweden2 sites in 2 countriesChoose a country to see its sites
Trial code
Status
Completed
People taking part
810 people enrolled
Started
Sept 2016
Ended
2 Oct 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Follitropin alpha
  • Menotropin
Record updated
17 March 2025

Who can take part

Age
25 years to 40 years
Sex
Women only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Normal ovulatory cycles 26-32 days
  • First and second IVF treatment
  • Indication for IVF is male factor, tubal factor or unexplained infertility
  • Medical indication for IVF; >12 months unprotected intercourse

Who cannot take part

  • polycystic ovarian syndrome
  • pre ovarian failure
  • male age more than 56
  • Anti Müllerian Hormone <5pmol or cycle day 2-3 FSH >12
  • Endometriosis
  • smoking

Where is this trial?

It has sites in 2 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

The aim is to be able to predict the hormonal response according to gonadotropin receptor genotype and hormone type used for treatment of women undergoing in vitro fertilization or egg donation.

Read full original descriptionShow less

Outcome will be measured as pregnancy success, live born babies and unwanted side effects.

The 2 groups in the trial

  • Follitropin alphaExisting treatment, for comparison

    Follitropin alpha (GONAL-f, Merck-Serono, Darmstadt, Germany), injections, dosage varying 1500-2500 IU, duration 2-5 days.

    Treatment: Follitropin alpha and Menotropin

  • MenotropinExisting treatment, for comparison

    Menotropin (Menopur, Ferring GmbH, Kiel, Germany), injections, dosage varying 1500-2500 IU, duration 2-5 days.

    Treatment: Follitropin alpha and Menotropin

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Clinical Study on Pharmacogenetics of Gonadotropin Receptors in Relation to Pregnancy and Life Birth Rate as Well as Unwanted Side Effects Such as Ovarian Hyper Stimulation Syndrome During Assisted Reproduction.
Record updated
17 March 2025